| Trisha Tyo, CNP | |
|
3999 Richmond Rd, Beachwood, OH 44122-6046 | |
| (740) 707-3874 | |
| Not Available |
| Full Name | Trisha Tyo |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 3999 Richmond Rd, Beachwood, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003394834 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | APRN.CNP.023218 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Hospitals Of Cleveland | Cleveland, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Hospitals Cleveland Medical Center | 3274431879 | 100 |
| University Hospitals Ahuja Medical Center Inc | 5496935538 | 55 |
News Archive
While pregnancy is considered full-term at 40 weeks, only some 5 percent of women actually give birth on their predetermined due date. Most OBGYNs recommend more frequent and more vigilant monitoring after 40 weeks and sometimes the artificial induction of labor. But many pregnant women refuse induction due to the risk of stress to the fetus or increased likelihood of requiring a caesarean section.
Lucideon, the materials technology company, together with 9 European consortium partners, has been awarded €3.9m (£2.8m) grant by the European Commission to train industry PhD researchers for the development of drug-free antibacterial materials used for medical applications, such as wound care and implants.
Survivors of many common cancers enjoy a mental and physical health-related quality of life equal to that of adults who have not had cancer, but survivors of other cancers are in poorer health, according to results published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
Researchers at the University of Pittsburgh School of Medicine have successfully induced human insulin-producing cells, known as beta cells, to replicate robustly in a living animal, as well as in the lab.
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has entered into a common stock purchase agreement with Seaside 88, LP, a private investment limited partnership. Seaside has committed to purchase up to 49,455,130 shares of Generex common stock.
› Verified 6 days ago
| Entity Name | University Hospitals Ahuja Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609189604 PECOS PAC ID: 5496935538 Enrollment ID: O20120424000026 |
News Archive
While pregnancy is considered full-term at 40 weeks, only some 5 percent of women actually give birth on their predetermined due date. Most OBGYNs recommend more frequent and more vigilant monitoring after 40 weeks and sometimes the artificial induction of labor. But many pregnant women refuse induction due to the risk of stress to the fetus or increased likelihood of requiring a caesarean section.
Lucideon, the materials technology company, together with 9 European consortium partners, has been awarded €3.9m (£2.8m) grant by the European Commission to train industry PhD researchers for the development of drug-free antibacterial materials used for medical applications, such as wound care and implants.
Survivors of many common cancers enjoy a mental and physical health-related quality of life equal to that of adults who have not had cancer, but survivors of other cancers are in poorer health, according to results published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
Researchers at the University of Pittsburgh School of Medicine have successfully induced human insulin-producing cells, known as beta cells, to replicate robustly in a living animal, as well as in the lab.
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has entered into a common stock purchase agreement with Seaside 88, LP, a private investment limited partnership. Seaside has committed to purchase up to 49,455,130 shares of Generex common stock.
› Verified 6 days ago
| Entity Name | University Hospitals Cleveland Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043747454 PECOS PAC ID: 3274431879 Enrollment ID: O20170728000888 |
News Archive
While pregnancy is considered full-term at 40 weeks, only some 5 percent of women actually give birth on their predetermined due date. Most OBGYNs recommend more frequent and more vigilant monitoring after 40 weeks and sometimes the artificial induction of labor. But many pregnant women refuse induction due to the risk of stress to the fetus or increased likelihood of requiring a caesarean section.
Lucideon, the materials technology company, together with 9 European consortium partners, has been awarded €3.9m (£2.8m) grant by the European Commission to train industry PhD researchers for the development of drug-free antibacterial materials used for medical applications, such as wound care and implants.
Survivors of many common cancers enjoy a mental and physical health-related quality of life equal to that of adults who have not had cancer, but survivors of other cancers are in poorer health, according to results published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
Researchers at the University of Pittsburgh School of Medicine have successfully induced human insulin-producing cells, known as beta cells, to replicate robustly in a living animal, as well as in the lab.
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has entered into a common stock purchase agreement with Seaside 88, LP, a private investment limited partnership. Seaside has committed to purchase up to 49,455,130 shares of Generex common stock.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Trisha Tyo, CNP 1333 Gladys Ave, Lakewood, OH 44107-2511 Ph: (710) 707-3874 | Trisha Tyo, CNP 3999 Richmond Rd, Beachwood, OH 44122-6046 Ph: (740) 707-3874 |
News Archive
While pregnancy is considered full-term at 40 weeks, only some 5 percent of women actually give birth on their predetermined due date. Most OBGYNs recommend more frequent and more vigilant monitoring after 40 weeks and sometimes the artificial induction of labor. But many pregnant women refuse induction due to the risk of stress to the fetus or increased likelihood of requiring a caesarean section.
Lucideon, the materials technology company, together with 9 European consortium partners, has been awarded €3.9m (£2.8m) grant by the European Commission to train industry PhD researchers for the development of drug-free antibacterial materials used for medical applications, such as wound care and implants.
Survivors of many common cancers enjoy a mental and physical health-related quality of life equal to that of adults who have not had cancer, but survivors of other cancers are in poorer health, according to results published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
Researchers at the University of Pittsburgh School of Medicine have successfully induced human insulin-producing cells, known as beta cells, to replicate robustly in a living animal, as well as in the lab.
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has entered into a common stock purchase agreement with Seaside 88, LP, a private investment limited partnership. Seaside has committed to purchase up to 49,455,130 shares of Generex common stock.
› Verified 6 days ago
Megan Hebb, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3609 Park East Dr Ste 207, Beachwood, OH 44122 Phone: 216-360-9449 | |
Ms. Shenika Todd, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 27030 Cedar Rd Apt 403, Beachwood, OH 44122 Phone: 216-337-9406 | |
Amrithpal Kaur Brar, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 25700 Science Park Dr Ste 210, Beachwood, OH 44122 Phone: 216-450-1613 | |
Ms. Sally Ann Yozipovich, RN, CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 26900 Cedar Rd, Beachwood, OH 44122 Phone: 216-839-3150 Fax: 216-839-3195 | |
Mrs. Samantha May Wilson, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 24100 Chagrin Blvd Ste 430, Beachwood, OH 44122 Phone: 216-255-5201 | |
Laura Nikole Erskine Penix, AGACNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 26900 Cedar Rd, Beachwood, OH 44122 Phone: 216-839-3000 |